Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Left Ventricular and Endothelial Function in Preeclampsia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00201500
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : August 4, 2016
Sponsor:
Collaborator:
Central Norway Regional Health Authority
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The purpose of this study is (1) to examine whether the left ventricular function is impaired in women with preeclampsia relative to healthy pregnant controls, (2) to examine whether the endothelial function is impaired in women with preeclampsia relative to healthy pregnant controls, and (3) to examine whether there is a post partum impairment in left ventricular and endothelial function.

Condition or disease
Preeclampsia

Layout table for study information
Study Type : Observational
Actual Enrollment : 39 participants
Observational Model: Case-Control
Official Title: Left Ventricular and Endothelial Function in Preeclampsia, a Case Control Study
Study Start Date : October 2004
Actual Primary Completion Date : December 2005
Actual Study Completion Date : March 2006

Resource links provided by the National Library of Medicine


Group/Cohort
preeclampsia
women with preeclampsia
controls
healthy pregnant women



Primary Outcome Measures :
  1. Left Ventricular Function [ Time Frame: 3 months ]
  2. Endothelial Function [ Time Frame: 3 months ]

Biospecimen Retention:   Samples With DNA
Blood samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Women with preeclampsia and women with normotensive pregnancies.
Criteria

Inclusion Criteria:

  • >18 years of age
  • Case: Clinical diagnosis of preeclampsia,
  • Control: Systolic BP <140 mmHg and diastolic BP <90 mmHg

Exclusion Criteria:

  • Known hypertension or other cardiovascular disease
  • Diabetes/gestational diabetes
  • Multiple gestation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00201500


Locations
Layout table for location information
Norway
NTNU
Trondheim, Norway, N-7491
Sponsors and Collaborators
Norwegian University of Science and Technology
Central Norway Regional Health Authority
Investigators
Layout table for investigator information
Study Chair: Stig A Slørdahl, Professor Norwegian University of Science and Technology
Publications of Results:
Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00201500    
Other Study ID Numbers: PEETLV
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: August 4, 2016
Last Verified: August 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications